FDA Opens Door to Quicker Approval of Osteoporosis Drugs

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — The FDA has given the green light to use hip total bone mineral density (BMD) as a validated surrogate endpoint for clinical trials of osteoporosis drugs, the FDA announced Friday. A BMD test measures calcium and other bone minerals…
:max_bytes(150000):strip_icc()/GettyImages-1340498203-2c56c0865c514502b29c8e4f8df181f8.jpg?w=390&resize=390,220&ssl=1)

